$8.87
N/A
Last update: Nov 4, 9:29 AM
SELLAS Life Sciences Group Inc
SLSNASDAQ
The average analyst price target for SELLAS Life Sciences Gr is $6.50, 26.7% below the current price. Of 2 analysts, 2 rate it Buy. Targets range from $3 to $10. The latest change came on Mar 12, 2026, when Maxim Group raised its price target on SELLAS Life Sciences Gr from $7 to $10 and kept a Buy rating.
Price Target Range — 3 Quarters
Analyst Consensus — 2 Analysts
Rating Trend — Last 9 Months
